SynthesisBMC cancer2021

Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer.

Jiayuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.